GSA Capital Partners »

Trevi Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $409k 122k 3.34

More positions owned by GSA Capital Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Global Ship Lease Com Cl A (GSL)
Staar Surgical Com Par $0.01 (STAA)
Progressive Corporation (PGR)
Accenture Plc Ireland Shs Class A (ACN)
Star Bulk Carriers Corp. Shs Par (SBLK)
Teck Resources CL B (TECK)
Vital Farms (VITL)
TJX Companies (TJX)
Fresh Del Monte Produce Ord (FDP)
Magnite Ord (MGNI)
Comcast Corp Cl A (CMCSA)

View all positions for GSA Capital Partners

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
Rubric Capital Management
Viking Global Investors
VR Adviser
BlackRock
BlackRock
Logos Global Management
Opaleye Management
Vanguard Group
MPM Oncology Impact Management
MAI Wealth Advisors
Geode Capital Management
State Street Corporation
Silverarc Capital Management

View all funds holding Trevi Therapeutics